Somatostatin, also known as somatotropin-release inhibitory factor, is a cyclopeptide that
exerts potent inhibitory actions on hormone secretion and neuronal excitability. Its …

This review is based on a presentation given at the Hans Popper Hepatopathology Society
companion meeting at the 2019 United States and Canadian Academy of Pathology Annual …

Neuroendocrine tumours (NETs) are neoplasms that arise from neuroendocrine cells.
Neuroendocrine cells and their tumours can secrete a wide range of amines and …

Simple Summary Pancreatic neuroendocrine tumors (pNETs) are rare, indolent cancers
whose causation is only partly understood. An increasing number of studies have uncovered …

Pancreatic neuroendocrine tumors (pNETs) are rare and part of the diverse family of
neuroendocrine neoplasms (NENs). Somatostatin receptors (SSTRs), which are widely …

Introduction: Recent advances in diagnostic modalities and therapeutic agents have raised
the importance of prognostic factors in predicting overall survival, as well as predictive …

Purpose Neuroendocrine neoplasms can occur as part of inherited disorders, usually in the
form of well-differentiated, slow-growing tumors (NET). The main predisposing syndromes …

Purpose Neuroendocrine tumors (NET) are rare cancers with variable behavior. A better
understanding of prognosis would aid individualized management. The aim of this …

Somatostatin (SST) is a small peptide that exerts inhibitory effects on a wide range of
neuroendocrine cells. Due to the fact that somatostatin regulates cell growth and hormone …

Background High grade gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN)
with a Ki67 proliferation index> 20%, include well-differentiated tumours grade 3 (NET G3) …